Although little is known about tumor cell entry into lymphatic vessels, multiple studies have demonstrated that cancer cells can express CC-chemokine receptor 7 (CCR7), which lymphocytes use to home to lymph nodes via CCL21 binding, in a sense, hijacking the lymphatic system to gain entry to lymphatic vessels and lymph nodes (151). The gene discussed is CCR7; the disease is cancer.